BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, May 25, 2026
Home » Topics » Analysis and data insight, Medical technology

Analysis and data insight, Medical technology
Analysis and data insight, Medical technology RSS Feed RSS

Med-tech gainers and losers for Nov. 17-21, 2025

Nov. 24, 2025
The top 10 med-tech stock gainers and losers for the week.
Read More

Med-tech gainers and losers for Nov. 10-14, 2025

Nov. 17, 2025
The top 10 med-tech stock gainers and losers for the week.
Read More

Med-tech gainers and losers for Nov. 3-7, 2025

Nov. 10, 2025
The top 10 med-tech stock gainers and losers for the week.
Read More

Med-tech gainers and losers for Oct. 27-31, 2025

Nov. 3, 2025
The top 10 med-tech stock gainers and losers for the week.
Read More

Med-tech gainers and losers for Oct. 20-24, 2025

Oct. 27, 2025
The top 10 med-tech stock gainers and losers for the week.
Read More

Med-tech gainers and losers for Oct. 13-17, 2025

Oct. 20, 2025
The top 10 med-tech stock gainers and losers for the week.
Read More
Pen and paper

White House ushering in new era of EO governance?

Oct. 15, 2025
By Mari Serebrov
No Comments
While the pace of executive orders (EOs) coming out of the White House has slowed, the Trump administration is still churning them out. As of the end of the third quarter, President Donald Trump had issued 209 EOs. Of those, BioWorld tracked 37 that directly impact drug and device R&D, regulatory burdens, pricing and market competition.
Read More

Med-tech gainers and losers for Oct. 6-10, 2025

Oct. 13, 2025
The top 10 med-tech stock gainers and losers for the week.
Read More

Med-tech gainers and losers for Sept. 29-Oct. 3, 2025

Oct. 6, 2025
The top 10 med-tech stock gainers and losers for the week.
Read More
Nobel Prize Treg illustration
Shared by industry scientists

2025 Nobel honors autoimmunity discoveries

Oct. 6, 2025
By Anette Breindl
No Comments
The Nobel Committee announced today that it has awarded the 2025 Nobel Prize in Physiology or Medicine to three scientists for their discovery of regulatory T cells, which are a critical part of the way the body prevents autoimmune attacks.
Read More
Previous 1 2 3 4 5 6 7 8 9 … 55 56 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 22, 2026.
  • Brain and DNA

    Sangamo presents primate data for prion suppressor ST-506

    BioWorld Science
    Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
  • TREM2 agonists detailed in Pfizer patent

    BioWorld Science
    Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
  • Red dart and target against blue sky

    Unmasking the X: EPAC2 shifts the fragile X landscape

    BioWorld
    Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
  • Skin irritation on hands

    Recludix presents STAT1/3 inhibitors for dermatological diseases

    BioWorld Science
    Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing